Literature DB >> 15100223

Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons.

Emi Hama1, Keiro Shirotani, Nobuhisa Iwata, Takaomi C Saido.   

Abstract

Neprilysin (NEP) is a rate-limiting amyloid beta peptide (Abeta)-degrading enzyme in the brain. We demonstrated previously that overexpression of neprilysin in primary cortical neurons remarkably decreased not only extracellular but also intracellular Abeta levels. To investigate the subcellular compartments where neprilysin degrades Abeta most efficiently, we expressed neprilysin chimeric proteins containing various subcellular compartment-targeting domains in neurons. Sec12-NEP, beta-galactoside alpha2,6-sialyltransferase-NEP, transferrin receptor-NEP, and growth-associated protein 43-NEP were successfully sorted to the endoplasmic reticulum, trans-Golgi network, early/recycling endosomes, and lipid rafts, respectively. We found that intracellularly, wild-type neprilysin and all the chimeras showed equivalent Abeta40-degrading activities. Abeta40 was more effectively cleared than Abeta42, and this tendency was greater for intracellular Abeta than for extracellular Abeta. Wild-type and trans-Golgi network-targeted ST-NEP cleared more intracellular Abeta42 than the other chimeras. Wild-type neprilysin cleared extracellular Abeta more effectively than any of the chimeras, among which endoplasmic reticulum-targeted Sec12-NEP was the least effective. These observations indicate that different intracellular compartments may be involved in the metabolism of distinct pools of Abeta (Abeta40 and Abeta42) to be retained or recycled intracellularly and to be secreted extracellularly, and that the endogenous targeting signal in wild-type neprilysin is well optimized for the overall neuronal clearance of Abeta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100223     DOI: 10.1074/jbc.M401891200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  The study of Golgi apparatus in Alzheimer's disease.

Authors:  Zhiping Hu; Liuwang Zeng; Zhiling Huang; Jie Zhang; Ting Li
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

2.  Curcumin inhibits the AKT/NF-κB signaling via CpG demethylation of the promoter and restoration of NEP in the N2a cell line.

Authors:  Yushuang Deng; Xi Lu; Li Wang; Tao Li; Yubin Ding; Huimin Cao; Yuping Zhang; Xiuming Guo; Gang Yu
Journal:  AAPS J       Date:  2014-04-23       Impact factor: 4.009

3.  HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytes.

Authors:  Xiqian Lan; Jiqing Xu; Tomomi Kiyota; Hui Peng; Jialin C Zheng; Tsuneya Ikezu
Journal:  J Immunol       Date:  2011-05-06       Impact factor: 5.422

4.  Potent amyloidogenicity and pathogenicity of Aβ43.

Authors:  Takashi Saito; Takahiro Suemoto; Nathalie Brouwers; Kristel Sleegers; Satoru Funamoto; Naomi Mihira; Yukio Matsuba; Kazuyuki Yamada; Per Nilsson; Jiro Takano; Masaki Nishimura; Nobuhisa Iwata; Christine Van Broeckhoven; Yasuo Ihara; Takaomi C Saido
Journal:  Nat Neurosci       Date:  2011-07-03       Impact factor: 24.884

5.  Distinct subcellular patterns of neprilysin protein and activity in the brains of Alzheimer's disease patients, transgenic mice and cultured human neuronal cells.

Authors:  Li Zhou; Chunsheng Wei; Wei Huang; David A Bennett; Dennis W Dickson; Rui Wang; Dengshun Wang
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

Review 6.  Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis.

Authors:  M Maulik; D Westaway; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2012-09-16       Impact factor: 5.590

7.  A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury.

Authors:  Xiao-Han Chen; Victoria E Johnson; Kunihiro Uryu; John Q Trojanowski; Douglas H Smith
Journal:  Brain Pathol       Date:  2008-05-19       Impact factor: 6.508

8.  Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.

Authors:  William J Meilandt; Moustapha Cisse; Kaitlyn Ho; Tiffany Wu; Luke A Esposito; Kimberly Scearce-Levie; Irene H Cheng; Gui-Qiu Yu; Lennart Mucke
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

9.  Choroid plexus implants rescue Alzheimer's disease-like pathologies by modulating amyloid-β degradation.

Authors:  Marta Bolos; Desireé Antequera; Jesús Aldudo; Henrike Kristen; María Jesús Bullido; Eva Carro
Journal:  Cell Mol Life Sci       Date:  2013-12-17       Impact factor: 9.261

10.  Overexpression of neprilysin reduces alzheimer amyloid-beta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila.

Authors:  Kanae Iijima-Ando; Stephen A Hearn; Linda Granger; Christopher Shenton; Anthony Gatt; Hsueh-Cheng Chiang; Inessa Hakker; Yi Zhong; Koichi Iijima
Journal:  J Biol Chem       Date:  2008-05-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.